Glenmark launches Teneligliptin + Pioglitazone Fixed-Dose Combination drug for type-II diabetes in India Read more
Need to ramp up India’s triple advantage of cost, quality and scale in pharma to next level, says DoP Secretary Read more
Dr Mandaviya inaugurates 7th international conference on ‘India Pharma & India Medical Device 2022’ Read more
Zydus announces publication of “Dream-ND” and “Dream-D” phase-III trials of Desidustat in “American Journal of Nephrology” Read more